Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
12.71
-0.13 (-1.01%)
At close: Apr 28, 2026, 4:00 PM EDT
12.89
+0.18 (1.42%)
After-hours: Apr 28, 2026, 7:38 PM EDT
TNXP Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 13.11 | 10.09 | 7.77 | - | - | |
| Revenue Growth (YoY) | 29.85% | 29.94% | - | - | - | |
| Cost of Revenue | 6.64 | 7.77 | 4.74 | - | - | |
| Gross Profit | 6.47 | 2.33 | 3.03 | - | - | |
| Selling, General & Admin | 87.68 | 40.1 | 34.75 | 30.22 | 23.47 | |
| Research & Development | 44.49 | 39.97 | 86.66 | 81.88 | 68.84 | |
| Operating Expenses | 132.17 | 80.07 | 121.41 | 112.09 | 92.31 | |
| Operating Income | -125.7 | -77.74 | -118.38 | -112.09 | -92.31 | |
| Interest Expense | -0.09 | -1.23 | - | - | - | |
| Interest & Investment Income | 4.15 | 0.02 | - | - | 0.03 | |
| Other Non Operating Income (Expenses) | -0.28 | 7.88 | 1.72 | 1.87 | - | |
| EBT Excluding Unusual Items | -121.93 | -71.08 | -116.66 | -110.22 | -92.29 | |
| Impairment of Goodwill | - | -1 | - | - | - | |
| Asset Writedown | - | -57.96 | - | - | - | |
| Other Unusual Items | -2.09 | - | - | - | - | |
| Pretax Income | -124.02 | -130.04 | -116.66 | -110.22 | -92.29 | |
| Net Income | -124.02 | -130.04 | -116.66 | -110.22 | -92.29 | |
| Preferred Dividends & Other Adjustments | - | - | - | 6.66 | - | |
| Net Income to Common | -124.02 | -130.04 | -116.66 | -116.88 | -92.29 | |
| Shares Outstanding (Basic) | 9 | 1 | - | - | - | |
| Shares Outstanding (Diluted) | 9 | 1 | - | - | - | |
| Shares Change (YoY) | 1055.90% | - | - | - | - | |
| EPS (Basic) | -14.57 | -176.60 | - | - | - | |
| EPS (Diluted) | -14.57 | -176.60 | - | - | - | |
| Free Cash Flow | -103.21 | -61.05 | -109.9 | -146.2 | -110.86 | |
| Free Cash Flow Per Share | -12.13 | -82.90 | - | - | - | |
| Gross Margin | 49.34% | 23.07% | 38.97% | - | - | |
| Operating Margin | -959.05% | -770.20% | -1523.94% | - | - | |
| Profit Margin | -946.22% | -1288.25% | -1501.78% | - | - | |
| Free Cash Flow Margin | -787.47% | -604.76% | -1414.75% | - | - | |
| EBITDA | -123.78 | -74.32 | -114.09 | -110.84 | -92.26 | |
| D&A For EBITDA | 1.93 | 3.42 | 4.29 | 1.25 | 0.05 | |
| EBIT | -125.7 | -77.74 | -118.38 | -112.09 | -92.31 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.